TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17186421

Group type: EXPERIMENTAL
Intervention: Tailored telephone-delivered and mailed intervention for smoking cessation
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Tailored telephone-delivered and mailed intervention for increased fruit and vegetable consumption
Number of subjects: 582

Group type: COMPARATOR
Intervention: Control group for smoking cessation
Number of subjects: 582

Group type: COMPARATOR
Intervention: Control group for fruit and vegetable consumption
Number of subjects: 582
Study: 10857960

Group type: EXPERIMENTAL
Intervention: KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Wheat bran fiber (WB) control biscuits
Number of subjects: 11
Study: 9170466

Group type: EXPERIMENTAL
Intervention: Domiciliary antenatal fetal monitoring
Number of subjects: 150

Group type: COMPARATOR
Intervention: In-hospital monitoring
Number of subjects: 150
Study: 1441495

Group type: EXPERIMENTAL
Intervention: Intensive smoking cessation program
Number of subjects: 6347

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6347
Study: 4022732

Group type: EXPERIMENTAL
Intervention: 8 20‐min. sessions of training in test‐taking skills particular to the Stanford Achievement Test
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not trained)
Number of subjects: 16
Study: 30548390

Group type: EXPERIMENTAL
Intervention: Metformin (n=27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups (Metformin and Placebo)
Number of subjects: 53
Study: 29795172

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - exercised twice a week at 85–95% of HRmax
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Training (MIT) - exercised three times a week at 70% of HRmax
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group - treatment as usual
Number of subjects: 30
Study: 27716200

Group type: EXPERIMENTAL
Intervention: Internet cognitive-behavioural therapy (CBT) with seven experimental factors (activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, absorption, self-compassion training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet cognitive-behavioural therapy (CBT) with seven experimental factors
Number of subjects: 0
Study: 24449235

Group type: EXPERIMENTAL
Intervention: Telephone counseling (TC)
Number of subjects: 669
Study: 22140146

Group type: EXPERIMENTAL
Intervention: Cigarettes with 10.1 μg ammonia per cigarette
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cigarettes with 18.9 μg ammonia per cigarette
Number of subjects: 34
Study: 20694295

Group type: EXPERIMENTAL
Intervention: Agaricus sylvaticus (30 mg/kg/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 18515949

Group type: EXPERIMENTAL
Intervention: Drug-regimens for fracture prevention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External hip protector use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of different drug-regimens
Number of subjects: 0
Study: 16164375

Group type: EXPERIMENTAL
Intervention: Non-medical and non-surgical therapies for palliative care
Number of subjects: 15
Study: 14523141

Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 114

Group type: COMPARATOR
Intervention: Isotonic-saline hydration (Control)
Number of subjects: 114
Study: 10551699

Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 452

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 452
Study: 8752795

Group type: EXPERIMENTAL
Intervention: Dobutamine transesophageal echocardiography (5 and 10 microg/min per kg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: F-18 fluorodeoxyglucose positron emission tomography
Number of subjects: 42

Group type: COMPARATOR
Intervention: Segments with recovery of regional left ventricular function
Number of subjects: 42

Group type: COMPARATOR
Intervention: Segments remaining akinetic after revascularization
Number of subjects: 42
Study: 2071200

Group type: EXPERIMENTAL
Intervention: Pugh nail-plate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 100
Study: 29793605

Group type: EXPERIMENTAL
Intervention: ABP-700 (infusion doses varying, continuous infusion for 30 minutes)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ABP-700 (higher dosages)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ABP-700 (upon ACTH stimulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol (60 μg kg-1 min-1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27758992

Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF assay
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combination of positive Xpert MTB/RIF, positive tuberculin skin test, heterogeneous echotexture of lymph nodes, or endosonographic coagulation necrosis sign
Number of subjects: 147
Study: 24810818

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study: 23242731

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% caudally (0.5 ml/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Levobupivacaine 0.25% caudally (0.5 ml/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bromage scale assessment for motor block
Number of subjects: 60
Study: 20216112

Group type: EXPERIMENTAL
Intervention: TPV/RTV 500/100
Number of subjects: 10

Group type: COMPARATOR
Intervention: TPV/RTV 500/200
Number of subjects: 10
Study: 18667394

Group type: EXPERIMENTAL
Intervention: FOLFIRI + gefitinib
Number of subjects: 100

Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 100
Study: 16129748

Group type: EXPERIMENTAL
Intervention: Medial opening-wedge high tibial osteotomy (HTO)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lateral closing-wedge high tibial osteotomy (HTO)
Number of subjects: 51
Study: 12538220

Group type: EXPERIMENTAL
Intervention: Brandt tube system
Number of subjects: 2

Group type: COMPARATOR
Intervention: Hi-Contour control
Number of subjects: 2
Study: 10989400

Group type: EXPERIMENTAL
Intervention: Routine care plus nurse home visits during pregnancy and through the child's second birthday (n = 116)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Routine care plus nurse home visits during pregnancy only (n = 100)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Routine perinatal care (control group; n = 184)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Home visitation during pregnancy and infancy (for mothers reporting 28 or fewer incidents of domestic violence)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Home visitation during pregnancy and infancy (for mothers reporting more than 28 incidents of domestic violence)
Number of subjects: 324
Study: 8903817

Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sulfate-free polyethylene glycol electrolyte lavage solution (SF-PEG-ELS)
Number of subjects: 98
Study: 1801541

Group type: EXPERIMENTAL
Intervention: Selegiline (S) 10 mg/day
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 93
Study: 6401507

Group type: EXPERIMENTAL
Intervention: Objective test for diagnosing Raynaud's phenomenon, based on thermal entrainment, non-invasive measurement of blood-flow responses.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 0
Study: 31278808

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (LAMB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meglumine antimoniate (MA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LAMB plus Meglumine antimoniate (MA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: LAMB vs MA
Number of subjects: 0
Study: 29046406

Group type: EXPERIMENTAL
Intervention: Cold Extrusion Rice (CER)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Hot Extrusion Rice 2 (HER2)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Coated Rice (COR)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Hot Extrusion Rice (HER)
Number of subjects: 41
Study: 27602665

Group type: EXPERIMENTAL
Intervention: Adalimumab (loading dose of 80 mg followed by 40 mg every 2 weeks)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 25000269

Group type: EXPERIMENTAL
Intervention: Mobile intervention for 14 days
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Mobile assessments (without intervention) for 14 days
Number of subjects: 94

Group type: COMPARATOR
Intervention: Minimal assessments (without intervention or mobile assessments)
Number of subjects: 94
Study: 22323412

Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Corneal nerve fiber length (CNFL)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Fiber density
Number of subjects: 89

Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Branch density
Number of subjects: 89

Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Tortuosity
Number of subjects: 89

Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Alternate threshold for sensitivity
Number of subjects: 89

Group type: COMPARATOR
Intervention: Corneal confocal microscopy (CCM) parameter - Alternate threshold for specificity
Number of subjects: 89
Study: 19745215

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccine
Number of subjects: 176

Group type: COMPARATOR
Intervention: Nonadjuvanted vaccine
Number of subjects: 176
Study: 17274828

Group type: EXPERIMENTAL
Intervention: CQR-300 (300 mg daily)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: CORE (1028 mg daily)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 16227771

Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy initiated in-hospital
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 0
Study: 11904654

Group type: EXPERIMENTAL
Intervention: Dobutamine (5 microg/kg per min) for 72 h
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline for 72 h
Number of subjects: 42
Study: 9461368

Group type: EXPERIMENTAL
Intervention: Infants with ALTE
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26
Study: 7888977

Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment (16 hours per day for 18 weeks)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo patch treatment
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment with gradual reduction
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment with dose increase after week 1
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment
Number of subjects: 1200
Study: 2198812

Group type: EXPERIMENTAL
Intervention: 0.5% betaxolol ophthalmic solution
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: 0.25% betaxolol suspension
Number of subjects: 352
Study: 857138

Group type: EXPERIMENTAL
Intervention: 300 mg/die Allopurinol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg/die Benzbromarone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg Allopurinol with 20 mg Benzbromarone
Number of subjects: 12

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 12
Study: 31852312

Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 183

Group type: COMPARATOR
Intervention: Home wound care professional
Number of subjects: 183

Group type: COMPARATOR
Intervention: Wound care clinic
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Telemedicine and home health care groups
Number of subjects: 183

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 183
Study: 30924163

Group type: EXPERIMENTAL
Intervention: EA-230 (90 mg/kg/hour for 2 hours)
Number of subjects: 80

Group type: COMPARATOR
Intervention: EA-230 (1, 3, 10, or 30 mg/kg single dosage)
Number of subjects: 80

Group type: COMPARATOR
Intervention: EA-230 (10, 20, or 30 mg/kg, thrice daily for 3 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: EA-230 (15, 30, or 90 mg/kg/hour for 2 hours)
Number of subjects: 80
Study: 29354954

Group type: EXPERIMENTAL
Intervention: No.1 treatment group (ginger-prepared paste)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: No.2 treatment group (honey-prepared paste)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: No.3 treatment group (honey-prepared paste, 6h application)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo group (pseudo-herbal paste)
Number of subjects: 160
Study: 25158837

Group type: EXPERIMENTAL
Intervention: True acupuncture (knee, scalp, and auricular acupuncture)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham auricular acupuncture
Number of subjects: 60
Study: 22771110

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo Taping (PT)
Number of subjects: 20
Study: 20544178

Group type: EXPERIMENTAL
Intervention: 800 mg of calcium and 400 IU of vitamin D3
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 40
Study: 18927162

Group type: EXPERIMENTAL
Intervention: General group-based exercise (GE) programme composed of resistance training and balance training exercises
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Flexibility exercise and relaxation technique (FR) programme
Number of subjects: 154

Group type: COMPARATOR
Intervention: No-exercise control (NEC)
Number of subjects: 154
Study: 17013513

Group type: EXPERIMENTAL
Intervention: Cell Saver (intraoperative red blood cell salvage)
Number of subjects: 41

Group type: COMPARATOR
Intervention: No Cell Saver (control group)
Number of subjects: 41
Study: 15380859

Group type: EXPERIMENTAL
Intervention: Olanzapine, 5-20 mg/day for 8 months
Number of subjects: 92
Study: 11576934

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuous Ambulatory Peritoneal Dialysis (CAPD)
Number of subjects: 50
Study: 9462601

Group type: COMPARATOR
Intervention: Short-term fractal scaling exponent (alpha1)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Long-term fractal scaling exponent (alpha2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Approximate entropy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard deviation of all RR intervals
Number of subjects: 38

Group type: COMPARATOR
Intervention: High-frequency spectral component of HR variability
Number of subjects: 38
Study: 8586772

Group type: EXPERIMENTAL
Intervention: Bovine Serum Albumin (BSA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ovine Serum Albumin (OSA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: BSA and OSA
Number of subjects: 16
Study: 2491707

Group type: EXPERIMENTAL
Intervention: Cefuroxime-axetil (250 mg twice daily after meal)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cefadroxil (1 g twice daily during meal)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cefuroxime-axetil
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cefadroxil
Number of subjects: 150
Study: 1062828

Group type: EXPERIMENTAL
Intervention: Training at 150 bpm heart rate
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Training 5 days/week
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Training 3 days/week
Number of subjects: 43

Group type: COMPARATOR
Intervention: Training 1 day/week
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Training 5 days/week vs 3 days/week
Number of subjects: 43
Study: 31934865

Group type: EXPERIMENTAL
Intervention: Online pain education program delivered through WeChat for 4 weeks
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 95
Study: 31745044

Group type: EXPERIMENTAL
Intervention: Phonophoresis with aceclofenac gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plain ultrasound
Number of subjects: 50
Study: 28558527

Group type: EXPERIMENTAL
Intervention: Positive frame
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Neutral frame
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Negative frame
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Trolley problem
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Footbridge dilemma
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Number of saved lives (5 or 15)
Number of subjects: 591
Study: 25816865

Group type: EXPERIMENTAL
Intervention: Vocational Enablement Protocol (VEP)
Number of subjects: 66
Study: 23636029

Group type: EXPERIMENTAL
Intervention: Reflexology therapy (AEDs + reflexology therapy)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Antiepileptic drugs (Control)
Number of subjects: 77
Study: 21305237

Group type: EXPERIMENTAL
Intervention: self-awareness plus compensatory prospective memory training
Number of subjects: 45

Group type: COMPARATOR
Intervention: self-awareness training plus active control
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: active control plus compensatory prospective memory training
Number of subjects: 45

Group type: COMPARATOR
Intervention: active control only
Number of subjects: 45
Study: 20029710

Group type: EXPERIMENTAL
Intervention: APOE genotype information
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Greater AD treatment optimism
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Lower perceived risk
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Higher perceived importance of genetics in the development of AD
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Lower perceived drawbacks of AD genetic testing
Number of subjects: 271
Study: 16484699

Group type: EXPERIMENTAL
Intervention: Thalidomide (100 mg/d orally, escalated to 400 mg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medroxyprogesterone (300 mg orally daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medroxyprogesterone
Number of subjects: 60
Study: 12723460

Group type: EXPERIMENTAL
Intervention: Propofol 2%
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diprivan
Number of subjects: 12
Study: 10651680

Group type: EXPERIMENTAL
Intervention: Cricoid pressure
Number of subjects: 100

Group type: COMPARATOR
Intervention: No cricoid pressure (Control)
Number of subjects: 100
Study: 8866631

Group type: EXPERIMENTAL
Intervention: Prazosin (1 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Urapidil (60 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 2023783

Group type: EXPERIMENTAL
Intervention: Reciprocating gait orthosis (RGO)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Hip guidance orthosis (HGO)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Neither orthosis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cost comparison
Number of subjects: 22
Study: 7034641

Group type: EXPERIMENTAL
Intervention: Ceforanide (0.5 g every 12 h)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cefazolin (1.0 g every 8 h)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ceforanide
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ceforanide and Cefazolin
Number of subjects: 54
Study: 29045315

Group type: EXPERIMENTAL
Intervention: ATP supplementation (400 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 27696395

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel at a dose of 175 mg/m2 plus nedaplatin at a dose of 80 mg/m2 administered intravenously every 3 weeks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel plus nedaplatin
Number of subjects: 27
Study: 26063925

Group type: EXPERIMENTAL
Intervention: Placebo analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Painful electrical stimulation
Number of subjects: 0
Study: 25190346

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (48 IU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21864416

Group type: EXPERIMENTAL
Intervention: RG-CMH (Chinese medicinal herb complex)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 20606545

Group type: EXPERIMENTAL
Intervention: Attendance at Camp Trillium
Number of subjects: 162

Group type: COMPARATOR
Intervention: Non-attendance at Camp Trillium
Number of subjects: 162
Study: 17645195

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 18
Study: 16134110

Group type: EXPERIMENTAL
Intervention: Interaction with thin-ideal confederate
Number of subjects: 119

Group type: COMPARATOR
Intervention: Interaction with average body dimensions confederate
Number of subjects: 119
Study: 12387959

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 606

Group type: COMPARATOR
Intervention: Microemulsified ciclosporin
Number of subjects: 606
Study: 9952201

Group type: EXPERIMENTAL
Intervention: Sildenafil (n = 136)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo (n = 132)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 268
Study: 8534461

Group type: EXPERIMENTAL
Intervention: 30 mg ketorolac IV
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 30 mg ketorolac IM
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 2725118

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system (TNS) 10, 20, and 40 mg/24 h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine system (TNS) delivering 14 mg nicotine/24 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 0
Study: 4902196

Group type: EXPERIMENTAL
Intervention: Protein-free liver extract (Ripason) administered both orally and intramuscularly
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 31068405

Group type: EXPERIMENTAL
Intervention: HIV text message
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control text message
Number of subjects: 17